NYSE GNC traded down $0.05 on Thursday, reaching $3.14. The company’s stock had a trading volume of 740,286 shares, compared to its average volume of 1,625,555. The firm has a market cap of $264.70 million, a PE ratio of 9.24, a price-to-earnings-growth ratio of 0.60 and a beta of 1.24. The business has a 50-day moving average price of $2.54 and a 200 day moving average price of $2.01. GNC has a 52 week low of $1.32 and a 52 week high of $3.50.
GNC (NYSE:GNC) last released its quarterly earnings results on Thursday, October 24th. The specialty retailer reported ($0.02) EPS for the quarter, missing the Zacks’ consensus estimate of $0.02 by ($0.04). The firm had revenue of $499.10 million during the quarter, compared to analyst estimates of $510.05 million. GNC had a net margin of 2.67% and a negative return on equity of 18.62%. GNC’s quarterly revenue was down 14.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.02 earnings per share. As a group, equities analysts forecast that GNC will post 0.28 EPS for the current year.
GNC Holdings, Inc, together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products. The company operates through three segments: U.S. and Canada, International, and Manufacturing/Wholesale. Its products include proteins, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty products, food and drink products, and other general merchandise.
See Also: How prevalent are 12b-1 fees?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.